Treatment of Hyperhidrosis: An Update

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Hyperhidrosis is a dermatosis presenting as pathologically excessive focal or generalized sweating. The stigmatizing nature of hyperhidrosis may cause patients to feel embarrassment and apprehension about their symptoms and experience a significant decrease in well-being. Severe cases of hyperhidrosis can also increase the risk of developing psychiatric and somatic comorbidities. Conventional non-surgical treatments of hyperhidrosis include aluminum salts, iontophoresis, botulinum toxin injections, and oral glycopyrronium. In recent years, new topical anticholinergic medications and devices have emerged that may improve the patients’ symptoms and even prevent the development of comorbidities. The treatment of hyperhidrosis can be a complex matter and may require the combination of several therapies. The purpose of this paper was to firstly review the literature on existing non-surgical treatment options for hyperhidrosis, and secondly provide a stepwise approach to investigating and treating patients with hyperhidrosis.

OriginalsprogEngelsk
TidsskriftAmerican Journal of Clinical Dermatology
Vol/bind23
Udgave nummer5
Sider (fra-til)635-646
Antal sider12
ISSN1175-0561
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
Mattias A.S. Henning was provided a grant for research from the LEO Foundation Denmark, grant number LF-18002. Dorra Bouazzi declares that she has no conflict of interest. Gregor B.E. Jemec reports grants and personal fees from AbbVie, personal fees from Coloplast, personal fees from Chemocentryx, personal fees from LEO pharma, grants from LEO Foundation, grants from Afyx, personal fees from Incyte, grants and personal fees from InflaRx, grants from Janssen-Cilag, grants and personal fees from Novartis, grants and personal fees from UCB, grants from CSL Behring, grants from Regeneron, grants from Sanofi, personal fees from Kymera, personal fees from VielaBio, outside the submitted work.

Funding Information:
Mattias A.S. Henning was provided a grant for research from the LEO Foundation Denmark, grant number LF-18002.

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Switzerland AG.

ID: 320657128